SARS-CoV-2 Antigen Rapid Qualitative Test Type A

Biotime 2 in 1 test kit can help the operator to distinguish the bacterial infection and viral infection, and improve the accuracy of clinical diagnosis of infectious diseases.

h-FABP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the heart-type fatty acid binding protein (h-FABP) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.

Myo is the earliest marker after AMI, and it is a sensitive and accurate indicator to judge whether there is reperfusion in thrombolytic therapy. Biotime Myo test kit is mainly used to detect Myo quantity in human serum and plasma samples.

COVID-19 Ag & Flu A/B Combo Self Test is a colloidal gold immunochromatography intended for the in vitro rapid, simultaneous qualitative detection and differentiation of N protein from SARS-CoV-2, influenza A and influenza B directly from nasal swab specimens obtained from individuals, who are suspected of COVID-19, influenza A or influenza B infection. Results are for the simultaneous identification of N protein of SARS-CoV-2, influenza A and influenza B.

TheToxoplasma IgG/IgM Rapid Test is an in vitro immunoassay for the in vitro qualitative determination of IgG and IgM class antibodies toToxoplasma gondii in human serum.IgG results with this assay are used to indicate past or recent infection withToxoplasma gondii. IgM results obtained with this assay are used as an aid in the diagnosis of acute or recentToxoplasma gondii infections. Toxoplasma IgM test shall not be used for prenatal screening of asymptomatic people, and the test results of this reagent shall not be used alone as the basis for termination of pregnancy. -Fluorescent immunoassay -Toxoplasma gondii infection -For in vitro diagnostic use only. For professional use only.

The HSV-2 IgG/IgM Rapid Test is an in vitro immunoassay for the qualitative determination of IgG and IgM class antibodies to HSV2 in human serum. The test is intended for use as an aid in the assessment of immune status and as an aid in the diagnosis of HSV infection. The HSV-2 IgM test shall not be used for prenatal screening of asymptomatic people, and the test results of this reagent shall not be used alone as the basis for termination of pregnancy. -Fluorescent immunoassay -Herpes simplex viruses2 (HSV-2) infection -For in vitro diagnostic use only. For professional use only.

β-HCG Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the β-human chorionic gonadotropin (β-HCG) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of reproductive hormones diseases.